News
Bird flu hype infecting biotech industry - NBC Newswww.nbcnews.com › wbna
www.nbcnews.com
7 Dec — Vical chief executive officer Vijay Samant says his company is among those pursuing a novel flu vaccine despite its SARS experience, ...
Vical drops cancer therapy after trial failure, shares plunge |...
www.reuters.com
Vical Inc said it would stop development of its most advanced drug, cancer therapy Allovectin, after a late-stage trial failed to show that the treatment was...
Get set for repairs - The Economic Times
economictimes.indiatimes.com
If your building is over 30 years old, better make sure it undergoes the repair and maintenance that it requires, particularly as the monsoon arrives, says...
Astellas Pharma US | Results for Cytomegalovirus Vaccine ASP0113 Trial
newsroom.astellas.us
Top-line results announced for Phase 3 trial of Cytomegalovirus vaccine ASP0113 in hematopoietic stem cell transplant recipients
sorted by relevance / date